CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 86 enrolled
Drug / intervention
Lung Ultrasoundother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05631756
NCT05631756N/ACompleted

"Correlation Between PaO2/FiO2 and Lung Ultrasound Score in Patients Admitted to an Intensive Care Unit With Interstitial Syndrome: A Prospective Physiological Study"

Cliniques universitaires Saint-Luc- Université Catholique de Louvain·interventional·Posted Nov 30, 2022·Updated Apr 30, 2026

In Brief

A clinical study evaluating Lung Ultrasound for Interstitial Lung Disease. Completed, enrolled 86 participants across 2 sites.

Detailed Summary

The goal of this physiological interventional prospective study is to evaluate the improvement of the previously demonstrated correlation between PaO2/ FiO2 and Lung Ultrasound score (LUSS) in patients admitted in the ICU with an intesrtitial syndrom (IS) on the ultrasound of all aetiologies at inclusion and at twenty four and forty eight hours. The main question it aims to answer is if the LUSS is a valid tool to evaluate the severity of the IS Participants will initially have an arterial blood gas to evaluate the PaO2/FiO2 and in the ten minutes a lung ultrasound to evaluate the LUSS. This will be repeated at twenty four and forty eight hours.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesBelgium
Collaborators--

Timeline

N/ACompletedFinished
2023202420252026
First PostedNov 30, 2022
Enrollment StartJan 26, 2023
Primary CompletionMay 13, 2025
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 3.6 years ago

Interventions

Lung Ultrasoundother

Evaluation of the Lung Ultrasound Score in patients presenting an interstitial syndrom on the lung ultrasound and to compare it with PaO2/FiO2